Zimmer Biomet Holdings
ZBH • NYSE
Zimmer Biomet Holdings is a medical - devices company in the healthcare sector trading on NYSE, led by CEO Ivan Tornos, with a market cap of $17.3B.
CEOIvan Tornos
Next Earnings
Upcoming earnings announcement for Zimmer Biomet Holdings
Date
Monday, May 4, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.86
Revenue Estimate
$2.1B
Earnings History
Past 12 earnings reports for Zimmer Biomet Holdings
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Q4 2025 | $2.42Est: $2.39 | +1.3% | $2.2BEst: $2.2B | +1.3% | — |
| Nov 5, 2025 | Q3 2025 | $1.90Est: $1.87 | +1.6% | $2.0BEst: $2.0B | -0.4% |  10-Q |
| Aug 7, 2025 | Q2 2025 | $2.07Est: $1.98 | +4.5% | $2.1BEst: $2.0B | +1.3% | 10-Q |
| May 5, 2025 | Q1 2025 | $1.81Est: $1.77 | +2.3% | $1.9BEst: $1.9B | +0.5% | 10-Q |
| Feb 6, 2025 | Q4 2024 | $2.31Est: $2.29 | +0.9% | $2.0BEst: $2.0B | +0.6% | 10-K |
| Oct 30, 2024 | Q3 2024 | $1.74Est: $1.73 | +0.6% | $1.8BEst: $1.8B | +1.3% | 10-Q |
| Aug 7, 2024 | Q2 2024 | $2.01Est: $1.99 | +1.0% | $1.9BEst: $1.9B | +0.1% | 10-Q |
| May 2, 2024 | Q1 2024 | $1.94Est: $1.87 | +3.7% | $1.9BEst: $1.9B | +1.0% | 10-Q |
| Feb 8, 2024 | Q4 2023 | $2.20Est: $2.15 | +2.3% | $1.9BEst: $1.9B | +0.5% | 10-K |
| Nov 7, 2023 | Q3 2023 | $1.65Est: $1.60 | +3.1% | $1.8BEst: $1.8B | +0.2% | — |
| Aug 1, 2023 | Q2 2023 | $1.82Est: $1.82 | 0.0% | $1.9BEst: $1.8B | +2.5% | 10-Q |
| May 2, 2023 | Q1 2023 | $1.89Est: $1.64 | +15.2% | $1.8BEst: $1.7B | +7.7% | 10-Q |